Natural antibodies in normal human serum inhibit staphylococcus aureus capsular polysaccharide vaccine efficacy

Clinical Infectious Diseases

Volumn 55, Issue 9, 2012, Pages 1188-1197

  Skurnik, David ^a   Kropec, Andrea ^b   Roux, Damien ^a   Theilacker, Christian ^b   Huebner, Johannes ^b   Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; N ACETYLGLUCOSAMINE; POLY N ACETYLGLUCOSAMINE; POLYSACCHARIDE; STAPHYLOCOCCUS VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTEREMIA; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; NORMAL HUMAN; OPSONIZATION; PRIORITY JOURNAL; SERUM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ACETYLGLUCOSAMINE; ADULT; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; BACTERIAL CAPSULES; HUMAN EXPERIMENTATION; HUMANS; MICE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS;

EID: 84867538804     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis624     Document Type: Article

References (27)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32.
2. McCaig LF, McDonald LC, Mandal S, Jernigan DB. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis 2006; 12:1715-23. (Pubitemid 44674248)
3. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-74.
4. Klevens RM, Edwards JR, Gaynes RP. The impact of antimicrobialresistant, health care-associated infections on mortality in the United States. Clin Infect Dis 2008; 47:927-30.
5. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-71. (Pubitemid 47598444)
6. Lee BY, Ufberg PJ, Bailey RR, et al. The potential economic value of a Staphylococcus aureus vaccine for neonates. Vaccine 2010; 28:4653-60.
7. Lee BY, Wiringa AE, Bailey RR, Lewis GJ, Feura J, Muder RR. Staphylococcus aureus vaccine for orthopedic patients: an economic model and analysis. Vaccine 2010; 28:2465-71.
8. Niessen LW, ten Hove A, Hilderink H, Weber M, Mulholland K, Ezzati M. Comparative impact assessment of child pneumonia interventions. Bull World Health Organ 2009; 87:472-80.
9. Bernatoniene J, Finn A. Advances in pneumococcal vaccines: advantages for infants and children. Drugs 2005; 65:229-55. (Pubitemid 40139384)
10. Trotter CL, McVernon J, Ramsay ME, et al. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 2008; 26:4434-45.
11. Swingler G, Fransman D, Hussey G. Conjugate vaccines for preventing Haemophilus influenzae type b infections. Cochrane Database Syst Rev 2009; 4:CD001729.
12. Lin FY, Ho VA, Khiem HB, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001; 344:1263-9. (Pubitemid 32372960)
13. Shinefield H, Black S, Fattom A, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002; 346:491-6. (Pubitemid 34441740)
14. Daum RS, Spellberg B. Progress toward a Staphylococcus aureus vaccine. Clin Infect Dis 2012; 54:560-7.
15. Spellberg B, Daum R. Development of a vaccine against Staphylococcus aureus. Semin Immunopathol 2012; 34:335-48.
16. Skurnik D, Merighi M, Grout M, et al. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest 2010; 120:3220-33.
17. Maira-Litran T, Kropec A, Goldmann DA, Pier GB. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly- N-acetyl-β-(1-6)-glucosamine. Infect Immun 2005; 73:6752-62. (Pubitemid 41368842)
18. Gening ML, Maira-Litran T, Kropec A, et al. Synthetic β-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun 2010; 78:764-72.
19. Granoff DM. Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease. Vaccine 2009; 27:B117-25.
20. Huang SS, Hinrichsen VL, Datta R, et al. Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detection. PLoS One 2011; 6:e24340.
21. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36:281-5. (Pubitemid 36169662)
22. Huang SS, Diekema DJ, Warren DK, et al. Strain-relatedness of methicillin- resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis 2008; 46:1241-7. (Pubitemid 351589909)
23. Fattom A, Schneerson R, Watson DC, et al. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A. Infect Immun 1993; 61:1023-32. (Pubitemid 23059663)
24. Broughan J, Anderson R, Anderson AS. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines. Exp Rev Vacc 2011; 10:695-708.
25. Thomsen I, Dudney H, Creech CB. Searching for the holy grail of a staphylococcal vaccine. Hum Vaccin 2010; 6:1068-70.
26. Cerca N, Maira-Litran T, Jefferson KK, Grout M, Goldmann DA, Pier GB. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proc Natl Acad Sci USA 2007; 104:7528-33. (Pubitemid 47185940)
27. Nemeth J, Lee JC. Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis. Infect Immun 1995; 63:375-80.